help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Di Cerbo, A.
Right arrow Articles by Corda, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Di Cerbo, A.
Right arrow Articles by Corda, D.

Journal of Clinical Endocrinology & Metabolism, Vol 74, 585-592, Copyright © 1992 by Endocrine Society

ARTICLES

Immunoglobulins from Graves' patients stimulate phospholipase-A2 in FRTL5 thyroid cells

A Di Cerbo, M Di Girolamo, V Guardabasso, V De Filippis and D Corda
Laboratory of Cellular and Molecular Endocrinology, Istituto di Ricerche Farmacologiche Mario Negri, Consorzio Mario Negri Sud, Chieti, Italy.

The well documented ability of immunoglobulins G (IgGs) from Graves' patients to stimulate cAMP production is believed to be involved in the pathophysiology of this disease. It is still under discussion whether other intracellular messengers known to regulate thyroid function might play a similar role. This study shows that phospholipase-A2, a signal pathway unrelated to cAMP, is activated by Graves' IgGs. The IgGs from 67 patients with active Graves' disease, 8 patients with Graves' disease in remission, 5 patients with idiopathic myxedema, 2 patients with Hashimoto's thyroiditis, 57 patients with nonautoimmune thyroid disease, and 65 normal subjects were tested for their ability to stimulate phospholipase-A2 activity, as measured by arachidonic acid release from FRTL5 thyroid cells. The IgGs from patients with active Graves' disease caused a significant increase in arachidonic acid release compared to those from normal subjects, patients with nonautoimmune thyroid diseases, and patients with Graves' disease in remission (P less than 0.0001). The IgGs from active Graves' patients were also able to increase cAMP accumulation in FRTL5 cells. This effect did not correlate with the ability of the same IgGs to induce arachidonic acid release, suggesting that Graves' IgGs stimulate these two pathways by separate mechanisms. Moreover, a subgroup of IgGs that stimulated phospholipase-A2 did not increase the cAMP levels in FRTL5 cells. Our data suggest a novel mechanism of action of Graves' IgGs, the activation of phospholipase-A2, well distinguishable from the known effect on cAMP accumulation. The assay we describe could be helpful in improving the diagnosis and therapy of Graves' disease and in distinguishing it from nonautoimmune thyroid diseases. It also supplies the basis for a prospective subclassification of the Graves' patients, which might become useful to clarify the pathophysiology of this disease.


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
T. Ohto, N. Uozumi, T. Hirabayashi, and T. Shimizu
Identification of Novel Cytosolic Phospholipase A2s, Murine cPLA2{delta}, {epsilon}, and {zeta}, Which Form a Gene Cluster with cPLA2{beta}
J. Biol. Chem., July 1, 2005; 280(26): 24576 - 24583.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Han and T. J. Smith
Cytoplasmic Prostaglandin E2 Synthase Is Dominantly Expressed in Cultured KAT-50 Thyrocytes, Cells That Express Constitutive Prostaglandin-endoperoxide H Synthase-2. BASIS FOR LOW PROSTAGLANDIN E2 PRODUCTION
J. Biol. Chem., September 20, 2002; 277(39): 36897 - 36903.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Di Cerbo, R. Di Paola, C. Menzaghi, V. De Filippis, K. Tahara, D. Corda, and L. D. Kohn
Graves' Immunoglobulins Activate Phospholipase A2 by Recognizing Specific Epitopes on Thyrotropin Receptor
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3283 - 3292.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
T. J. Smith, T. A. Jennings, D. Sciaky, and H. J. Cao
Prostaglandin-endoperoxide H Synthase-2 Expression in Human Thyroid Epithelium. EVIDENCE FOR CONSTITUTIVE EXPRESSION IN VIVO AND IN CULTURED KAT-50 CELLS
J. Biol. Chem., May 28, 1999; 274(22): 15622 - 15632.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. D. Kohn, K. Suzuki, W. H. Hoffman, D. Tombaccini, C. Marcocci, N. Shimojo, Y. Watanabe, N. Amino, B. Y. Cho, Y. Kohno, et al.
Characterization of Monoclonal Thyroid-Stimulating and Thyrotropin Binding-Inhibiting Autoantibodies from a Hashimoto's Patient Whose Children Had Intrauterine and Neonatal Thyroid Disease
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 3998 - 4009.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Di Paola, C. Menzaghi, V. De Filippis, D. Corda, and A. Di Cerbo
Cyclooxygenase-Dependent Thyroid Cell Proliferation Induced by Immunoglobulins from Patients with Graves' Disease
J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 670 - 673.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society